Featured
-
-
Translational Therapeutics
| Open AccessA pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
- W J Lesterhuis
- , I J M de Vries
- & C J A Punt
-
Epidemiology
| Open AccessSerum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
- G Bobe
- , G Murphy
- & A J Cross
-
Translational Therapeutics
| Open AccessIdentification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
- V Goede
- , O Coutelle
- & U T Hacker
-
Epidemiology
| Open AccessAntidepressant use and colorectal cancer risk: a Danish population-based case–control study
- D P Cronin-Fenton
- , A H Riis
- & H T Sørensen
-
Clinical Study
| Open AccessThe relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer
- C H Richards
- , E F Leitch
- & D C McMillan
-
Clinical Study
| Open AccessEstimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy
- J Bernhard
- , D Dietrich
- & R Herrmann
-
Clinical Study
| Open AccessAdjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α
- M Kornmann
- , L Staib
- & K-H Link
-
Letter to the Editor
| Open AccessIs GAPDH a relevant housekeeping gene for normalisation in colorectal cancer experiments?
- J Caradec
- , N Sirab
- & S Loric
-
Molecular Diagnostics
| Open AccessRole of human tissue kallikrein in gastrointestinal stromal tumour invasion
- P Dominek
- , P Campagnolo
- & P Madeddu
-
Letter to the Editor
| Open AccessReply: Cetuximab in small bowel adenocarcinoma: a new friend?
- M J Overman
- , R A Wolff
- & H Wang
-
Letter to the Editor
| Open AccessCetuximab in small bowel adenocarcinoma: a new friend?
- D Santini
- , M E Fratto
- & G Tonini
-
Molecular Diagnostics
| Open AccessPrognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
- C Bengala
- , S Bettelli
- & P F Conte
-
Molecular Diagnostics
| Open AccessmicroRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
- J Zhang
- , Y Yang
- & W Zhou
-
Molecular Diagnostics
| Open AccessBeclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia
- M I Koukourakis
- , A Giatromanolaki
- & A L Harris
-
Translational Therapeutics
| Open AccessElevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice
- T Matsuoka
- , J E Adair
- & J D Roberts
-
Clinical Study
| Open AccessLoss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer
- Y Okugawa
- , C Miki
- & M Kusunoki
-
Clinical Study
| Open AccessA clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer
- D C McMillan
- , C S McArdle
- & D S Morrison
-
Molecular Diagnostics
| Open AccessPrognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer
- Y Baba
- , K Nosho
- & S Ogino
-
Clinical Study
| Open AccessA randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
- T-S Yang
- , S-N Lu
- & L-T Chen
-
Clinical Study
| Open AccessUbiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
- D-W Yan
- , D-W Li
- & Z-H Peng
-
Epidemiology
| Open AccessIntake of wholegrain products and risk of colorectal cancers in the Diet, Cancer and Health cohort study
- R Egeberg
- , A Olsen
- & A Tjønneland
-
Molecular Diagnostics
| Open AccessTumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
- N Hiraoka
- , Y Ino
- & Y Kanai
-
Short Communication
| Open AccessInsulin-like growth factors and liver cancer risk in male smokers
- J M Major
- , R Z Stolzenberg-Solomon
- & D Albanes
-
Translational Therapeutics
| Open AccessSelective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells
- A Strillacci
- , C Griffoni
- & E Spisni
-
Translational Therapeutics
| Open AccessActivity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
- A Santoro
- , T Pressiani
- & C Bordignon
-
Molecular Diagnostics
| Open AccessThymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma
- S Lee
- , Y H Park
- & Y-H Im
-
Epidemiology
| Open AccessSex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma
- M Rutegård
- , H Nordenstedt
- & P Lagergren
-
Short Communication
| Open AccessPrevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey
- Z He
- , Y Zhao
- & Y Ke
-
Molecular Diagnostics
| Open AccessTargeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75
- M C Ryan
- , H Kostner
- & L M Smith
-
Translational Therapeutics
| Open AccessIntegrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
- I Garrido-Laguna
- , A C Tan
- & M Hidalgo
-
Clinical Study
| Open AccessUnderstanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom
- F H Shabaruddin
- , R A Elliott
- & K Payne
-
Epidemiology
| Open AccessCombined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea
- E H Yun
- , M K Lim
- & E-C Park
-
Genetics and Genomics
| Open AccessAssociation studies on 11 published colorectal cancer risk loci
- S von Holst
- , S Picelli
- & A Lindblom
-
Epidemiology
| Open AccessAlcohol intake and risk of colorectal cancer: Results from the UK Dietary Cohort Consortium
- J Y Park
- , C C Dahm
- & S A Rodwell
-
Short Communication
| Open AccessCellular senescence predicts treatment outcome in metastasised colorectal cancer
- A M Haugstetter
- , C Loddenkemper
- & C A Schmitt
-
Genetics and Genomics
| Open AccessWnt signalling in adenomas of familial adenomatous polyposis patients
- G M Caldwell
- , C E Jones
- & G M Matthews
-
Genetics and Genomics
| Open Accesshsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations
- F Wang
- , X Xue
- & Y Miao
-
Clinical Study
| Open AccessGemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
- T Okusaka
- , K Nakachi
- & Y Nimura
-
Clinical Study
| Open AccessMulti-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
- M Cosimelli
- , R Golfieri
- & F Izzo
-
Molecular Diagnostics
| Open AccessInverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma
- T Maruyama
- , K Mimura
- & K Kono
-
Genetics and Genomics
| Open AccessUGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
- E Martinez-Balibrea
- , A Abad
- & V Moreno
-
Molecular Diagnostics
| Open AccessPrognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
- A Lugli
- , G Iezzi
- & I Zlobec
-
Translational Therapeutics
| Open Access5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency
- K Bracht
- , A M Nicholls
- & W F Bodmer
-
Molecular Diagnostics
| Open AccessDiscovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
- A Xue
- , C J Scarlett
- & R C Smith
-
Clinical Study
| Open AccessA prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region
- P A Cassier
- , F Ducimetière
- & I Ray-Coquard
-
Clinical Study
| Open AccessClinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
- L J M Mekenkamp
- , M Koopman
- & C J A Punt
-
Molecular Diagnostics
| Open AccessIncreased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer
- S Takano
- , K Sogawa
- & M Miyazaki
-
Molecular Diagnostics
| Open AccessDetection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy
- P Kelly
- , V Appleyard
- & A Thompson
-
Letter to the Editor
| Open AccessRegarding: ‘Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array’
- J Pander
- , H Gelderblom
- & H-J Guchelaar